Sativex^®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.5, 2006-04, pp. : 607-615

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions

Medicinal Chemistry, Vol. 14, Iss. 2, 2018-02 ,pp. : 106-119

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs Treatment of Pain in Multiple Sclerosis

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. : 227-233

Bentham Science Publishers

Access to resources Recommend Favorite

Managing neuropathic pain with Sativex^®: a review of its pros and cons

By Perez Jordi Ribera Mª Victoria

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1189-1195

Informa Healthcare

Access to resources Recommend Favorite

Carbamazepine seems to have efficacy in the treatment of peripheral neuropathic pain

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain

By Tanasescu Radu Constantinescu Cris S

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1219-1228

Informa Healthcare

Access to resources Recommend Favorite